Analyst consensus rating
Nephros Analyst Rating: Buy
NEPH is rated Buy by 3 analysts with a $6.25 target. As of 2026-08-19.
Direct answer
Nephros's consensus rating is Buy.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $6.25.
Forecast evidence checked August 19, 2026.
Get free Nephros email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.60
- Average price target
- $6.25
- High price target
- $8.00
- Low price target
- $4.75
- Low target gap
- +3.3%
- Target upside
- +35.9%
- High target gap
- +73.9%
- Target range width
- 70.7%
- Consensus rating
- Buy
- Analysts
- 3
- Evidence date
- August 19, 2026
- Valid through
- August 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Nephros?
Nephros has a verified Buy consensus. The same dataset has an average price target of $6.25.
How far are Nephros's low and high targets from the recorded price?
The low target implies +3.3%, while the high target implies +73.9%.
How many analysts are included in Nephros's consensus?
The verified consensus includes 3 analysts.
How is Nephros's target upside or downside calculated?
The average target of $6.25 is divided by the recorded price of $4.60, then one is subtracted to produce +35.9%. This does not guarantee a future return.
When was Nephros's analyst forecast verified?
The data was verified on 2026-08-19. The dataset is valid through 2026-08-26.